# Anti-virals & HIV
<!-- toc -->
# Antivirals
## Antivirals General Principles
### Goal: Prevent viral replication
### Nucleoside vs. Nucleotide
* Nucleoside: Base + Sugar
* Nucleotide: Base + Sugar + Phosphate
### **How?**
* **Terminate replicating chain- Inhibit viral DNA Polymerase**
  * **NucleoSIDE analogue**: Acyclovir, Ganciclovir, Trifluridine
  * **NucleoTIDE analogue**: Cidofovir
* **Directly inhibit DNA/RNA Polymerase**
  * Foscarnet
* **Inhibit new base synthesis X**
  * Ribavirin
* **Inhibit virion release from cells**
  * Oseltamivir
* **Inhibit viral uncoating**
  * Amantadine

## Herpes/Varicella Zoster/CMV

### Acyclovir & VALAciclovir
*MOA:*
* Guanosine analogue (NucleoSIDE)- Phosphorylated by **viral thymidine Kinase**, inhibits viral DNA polymerase by chain termination.
* Prefers viral cells

*Use:*
* **HSV** Encephalitis and Ulcers
* **VZV**

*SE:*
* Concentrates in kidneys - **Acute renal failure if dehydrated**

### Ganciclovir & VALGANCciclovir
*MOA:*
* Guanosine analogue (NucleoSIDE), phosphorylated by **CMV viral kinase**, inhibits DNA polymerase
* Goes into viral and human cells

*Use:*
* **CMV**
  * Retinitis, systemic, prophylaxis in transplant patients

*SE:*
* More toxic than acyclovir
* **Bone marrow suppression (Neutropenia)**
* Renal failure

## Viral Respiratory Infections

### Oseltamivir & Zanamivir
*MOA:* **Neuraminidase Inhibitor**
* Influenza virus attaches to host cell using hemagglutinin via sialic acid
* Neuraminidase cleaves sialic acid and allows virus to be release
* **Drug inhibit viral progeny release from host cells by inhibiting Neuraminidase enzyme**

*Use:*
* Influenza A & B
* Use within 48 hours of sx
* Shortens duration of iliness
* Can be used as prophylaxis

*SE:*
* Zanamivir- Inhaled-Bronchospasm

### Ribavirin
*MOA:*
* Inhibits **IMP dehydrogenase**
* Leading to **inhibiting guanine nucleotide synthesis**
* Leading to **inhibiting viral mRNA synthesis**

*Use:*
* Aerosol - **RSV in children**
* Oral - **Hepatitis B& C**

*SE:*
* Anemia
* ****Teratogenic****

### Amantadine
*MOA:* Inhibits M2 protein used for viral uncoating

Not used for Flu anymore - Used for PD

## Hepatitis
### Interferon Alpha
*MOA:*
* Interferes with viral protein synthesis

*Use:*
* Hepatiis B/ C + Ribavirin - **NOT CURATIVE**

*SE:*
* **Depression**
* Myopathy
* **Neutropenia**

*Side note*

* Interferon *Alpha* - Tx viral and cancer stuff
* Interferon *Beta* - Tx Multiple Sclerosis
* Interferon *Gamma* - Chronic Granulomatous Disease

### Ribavirin
* Hepatitis B & C with interferon

### Ledipasivir / Sofosbuvir (Harvoni) & Ledipasivir / Simeprevir
*MOA:*
* **Ledipasivir**
  * Inhibit NSSA (involved in viral replication)
* **Sofosbuvir**
  * Incorporated into RNA and acts as chain terminator
  * Inhibit RNA dependent DNA polymerase
* **Simeprevir**
  * HCV protease inhibitor

*Use:*
* Hepatitic C
* **Harvoni - Curative in Combo**

**Cost**
* $100,000 for 12 weeks
* $1000 per pill

## Antivirals Summary
**Viruses AND Drugs**
* **HSV**= Acyclovir- Foscarnet-Trifluridine
* **VZV**= Acyclovir
* **CMV**= Ganciclovir- Foscarnet- Cidofovir
* **Influenza**= Oseltamivir, Amantadine
* **RSV**= Ribavirin
* **HBV**
  * Tenofovir + Lamivudine
  * Interferon + Ribavirin (Not prefered)
* **HCV**
  * Curative = Ledipasvir/Sofosbuvir +/- Ribavirin

# HIV Treatment
## HIV Treatment General Principles
### Goal: Prevent viral replication
### How?
* **Inhibit HIV fusion into host cells**
  * *Prevent docking*: Maraviroc
  * *Prevent fusion and entry*: Enfuvirtide
* **Inhibit reverse transcriptase**
  * *Via nucleoSIDES*: NRTI (Emtricitabine/Abacavir/Lamivudine/Zidovudine)
  * *Via nucleoTIDES*: NtRTI (Tenofovir)
  * *Via non-nucleosides*: NNRTI (Efavirenz)
* **Inhibit HIV integration into host cell genome**
  * *Integrase inhibitors* (Suffix-gravir)
* **Inhibit new virus maturation**
  * *Protease Inhibitors*: (Suffix-navir)

## Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
### Emtricitabine & Abacavir & Lamivudine & Zidovudine
*MOA:*
* Inhibit nucleotide binding to reverse transcriptase - Terminate DNA chain
* Need to be phosphorylated

*Use:*
* **Backbone of HAART**
* Lamivudine= HIV + Hepatitis B
* ***Zidovudine***
  * **Pregnant HIV mothers**
  * **Prophylaxis for infants @ risk**

*SE:*
* **Abacavir - Hypersensitivity if HLA-B5701 mutation**
* Zidovudine - Myelosuppression, Lipodystrophy
* Didanosine - ****Pancreatitis****

## Nucleotide Reverse Transcriptase Inhibitors (NtRTI)
### Tenofovir
*MOA:*
* Terminate DNA chain by inhibiting reverse transcriptase
* Does not need to be phosphorylated

*Use:*
* **Mainly used to boost levels of protease inhibitors (Booster)**
  * Tenofovir inhibits CYP 450
  * Protease inhibitors are metabolized via CYP 450
* Active against Hepatitis B

## Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
### Efavirenz, Rilpivirine, Etravirine
*MOA:*
* Inhibit reverse transcriptase @ site different than NRTI
* Do not need phosphorylation

*Use:*
* HAART

*SE:*
* Vivid dreams
* Contraindicated in pregnancy

**Drug interactions**
* Decrease levels of barbiturates and anticonvulsants
* Efavirenz levels will be decreased by Rifampin

## Protease Inhibitors
### Atazanavir & Lopinavir & Ritonavir &** Suffix **-navir
*MOA:*
* **Inhibit HIV 1 protease which cleaves HIV polypeptide products into functional parts**
* Prevent maturation of new viruses

*Use:*
* HAART

*SE:*
* **Lipodystrophy**
* Hyperglycemia and Dyslipidemia

LOTS of drug interactions
* **Ritonavir is used to boost levels of Pls**

## Integrase Inhibitors
### Raltegravir (Suffix -gravir)
*MOA:*
* Inhibit **HIV integrase** thus inhibiting HIV genome htegration into host cell chromosomes

*Use:*
* HAART

*SE:*
* Increase Creatine kinase

## Fusion Inhibitors
*Basics*: HIV uses gp proteins to bind to host cells
* *Gp-120*: **attaches** to CCRS5 receptor on macrophages, CXCR4 on T cells
* *Gp-41*: required for **fusion and entry**

### Enfuvirtide
*MOA:* Binds **gp-41** (block entry)

*Use:* Subcutaneous in HAART

*SE:* Injection site rxn

### Maraviroc
*MOA:* Binds CCRS5 - Inhibit attachment/Docking

## HIV Summary
### Who gets treated?
* HIV diagnosis regardless of CD4 count
* Especially if CD4 < 500
* AIDS defining illness
* Pregnant mothers, infants @ risk: **Zidovudine**
### Regimens
* Combo to prevent resistance - usually 3 medications
* Backbone is **2 NRTI (Efavirenz, Emtricitabine or Abacavir)**
* Plus one of the following
  * Protease inhibitors
  * Integrase inhibitors
  * Fusion inhibitors
  * NNRTI

## Prophylaxis in HIV Patients
* *Pneumocystis Jiroveci Pneumonia (PJP/PCP)*
  * **CD4<200**
  * Prophylaxis
    * **SMX/TMP**
    * ***Dapsone/Pentamidine*** for Sulfa allergy
* *Toxoplasmosis*
  * **CD4<100**
  * Prophylaxis
    * **SMX/TMP**
    * Dapsone for Sulfa allergy
* *Mycobacterium Avium Complex*
  * **CD4<50**
    * Prophylaxis
      * **Azithromycin** or clarithromycin
